Arch Therapeutics Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
ARTH Over the counter 3841 https://www.archtherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arch Therapeutics Inc

Arch Therapeutics Completes Leadership Team with Appointment of Dan Yrigoyen as Vice President of Sales - Jul 12th, 2021 11:50 am
Arch Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference, July 13 - 14, 2021 - Jul 7th, 2021 11:50 am
Arch Therapeutics to Present at the LD Micro Invitational XI, June 8 - 10, 2021 - Jun 2nd, 2021 11:50 am
Arch Therapeutics’ AC5® Advanced Wound System Presents with Recognition at the 2021 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) - May 10th, 2021 11:50 am
Arch Therapeutics Appoints Michael S. Abrams its Chief Financial Officer - May 3rd, 2021 11:50 am
Arch Therapeutics to Present AC5® Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC) - Apr 27th, 2021 11:50 am
Arch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical Results - Apr 19th, 2021 11:50 am
Arch Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference, March 9-10, 2021 - Mar 2nd, 2021 12:50 pm
Arch Therapeutics Announces Closing of $6.9 Million Private Placement - Feb 18th, 2021 12:50 pm
Arch Therapeutics Announces $6.9 Million Private Placement - Feb 12th, 2021 5:45 am
Arch Therapeutics to Present at the H.C. Wainwright BioConnect Conference, January 11 - 14, 2021 - Jan 5th, 2021 12:55 pm
Arch Therapeutics Announces Distribution Agreement with Buffalo Supply, Inc. - Jan 4th, 2021 12:50 pm
Arch Therapeutics to Present at the 13th Annual LD Micro Main Event Conference - Dec 11th, 2020 12:50 pm
Arch Raises Approximately $1.1 Million with Convertible Note Issuance - Nov 10th, 2020 12:50 pm
Arch Therapeutics’ AC5 Advanced Wound System Presented at the 2020 Symposium on Advanced Wound Care (SAWC) Fall - Nov 9th, 2020 12:50 pm
Arch Therapeutics, Inc. to Present at the Virtual Investor KOL Roundtable - Oct 22nd, 2020 11:50 am
Arch Therapeutics Announces Presentations on AC5 Advanced Wound System at the 2020 Symposium on Advanced Wound Care (SAWC) Fall - Oct 14th, 2020 11:50 am
With FDA and EU Marketing Authorizations in Hand, 2020 and 2021 Can Be Catalyst Years for Arch Therapeutics - Sep 22nd, 2020 12:30 pm
Arch Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15 at 12 PM ET - Sep 10th, 2020 11:50 am
LD Micro: 360 Companies Set to Present this Week - Aug 31st, 2020 10:05 pm